Atorable 10 Tablet – Atorvastatin 10mg

Manufacturing & Quality Standards

Product Overview

Packaging Details

Packaging Details
Why Include Atorable 10 in Your Cardiac Portfolio

Home/Products /atorvastatin-calcium-i-point-p-10mg-tablet

Atorable 10 Tablet

Composition : Atorvastatin Calcium I.P. 10mg Tablets

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹53/-

Manufacturing & Quality Standards

Atorable 10 Tablet is manufactured by Akums, a leading pharmaceutical manufacturer operating under WHO-GMP compliant facilities. The product follows standardized manufacturing protocols, batch-wise quality control checks, and regulated documentation systems to ensure consistent quality, safety, and reliability for pharmaceutical trade distribution.

Product Overview

Atorable 10 Tablet is a branded cardiac care formulation from Cafoli Lifecare’s Cadray division, which is dedicated exclusively to cardiac, diabetic, and chronic care medicines. The product is positioned for PCD pharma franchise distribution, wholesale supply, and institutional procurement across India.

The formulation is developed to support long-term inclusion in chronic care portfolios managed by pharmaceutical distributors and franchise partners.

  • Consistent batch-to-batch formulation quality
  • Accurate composition and dosage labeling
  • Professional-grade Alu-Alu packaging
  • Compliance with Indian pharmaceutical regulations

Packaging Details

  • 10 x 10 tablets Alu-Alu blister packing
  • Uniform tablet appearance across batches
  • Secure outer carton with complete regulatory labeling
  • Packaging suitable for safe logistics handling and inventory storage
Target Trade Segment (B2B)
  • Cardiac PCD Pharma Franchise Partners
  • Pharmaceutical Distributors & Stockists
  • Institutional & Bulk Medicine Suppliers
  • Hospital and Clinic Supply Chains

Atorable 10 Tablet is supplied strictly through pharmaceutical trade channels and is not positioned for direct-to-consumer sale.

Availability & Supply
  • Consistent stock availability for chronic therapy portfolios
  • Transparent and timely dispatch systems
  • GST-compliant invoicing and batch traceability
  • Trade-supportive MOQ options for franchise partners
Why Include Atorable 10 in Your Cardiac Portfolio
  • Manufactured by WHO-GMP compliant Akums facilities
  • Stable formulation suitable for chronic care distribution
  • Part of Cafoli Lifecare’s focused Cadray cardiac division
  • Designed for long-term distributor and franchise portfolio growth
  • Backed by ethical marketing and compliance-driven practices

Read More

About the Product

Manufacturing & Quality Standards

Atorable 10 Tablet is manufactured by Akums, a leading pharmaceutical manufacturer operating under WHO-GMP compliant facilities. The product follows standardized manufacturing protocols, batch-wise quality control checks, and regulated documentation systems to ensure consistent quality, safety, and reliability for pharmaceutical trade distribution.

Product Overview

Atorable 10 Tablet is a branded cardiac care formulation from Cafoli Lifecare’s Cadray division, which is dedicated exclusively to cardiac, diabetic, and chronic care medicines. The product is positioned for PCD pharma franchise distribution, wholesale supply, and institutional procurement across India.

The formulation is developed to support long-term inclusion in chronic care portfolios managed by pharmaceutical distributors and franchise partners.

  • Consistent batch-to-batch formulation quality
  • Accurate composition and dosage labeling
  • Professional-grade Alu-Alu packaging
  • Compliance with Indian pharmaceutical regulations

Packaging Details

  • 10 x 10 tablets Alu-Alu blister packing
  • Uniform tablet appearance across batches
  • Secure outer carton with complete regulatory labeling
  • Packaging suitable for safe logistics handling and inventory storage
Target Trade Segment (B2B)
  • Cardiac PCD Pharma Franchise Partners
  • Pharmaceutical Distributors & Stockists
  • Institutional & Bulk Medicine Suppliers
  • Hospital and Clinic Supply Chains

Atorable 10 Tablet is supplied strictly through pharmaceutical trade channels and is not positioned for direct-to-consumer sale.

Availability & Supply
  • Consistent stock availability for chronic therapy portfolios
  • Transparent and timely dispatch systems
  • GST-compliant invoicing and batch traceability
  • Trade-supportive MOQ options for franchise partners
Why Include Atorable 10 in Your Cardiac Portfolio
  • Manufactured by WHO-GMP compliant Akums facilities
  • Stable formulation suitable for chronic care distribution
  • Part of Cafoli Lifecare’s focused Cadray cardiac division
  • Designed for long-term distributor and franchise portfolio growth
  • Backed by ethical marketing and compliance-driven practices

Some patients may experience mild side effects such as muscle pain, weakness, digestive upset, or headache. In rare cases, more serious effects like liver enzyme abnormalities or muscle damage (rhabdomyolysis) can occur. Seek medical attention if unusual muscle pain or fatigue develops.

Indicated for the treatment of high cholesterol, prevention of heart attack or stroke, and in patients with existing cardiovascular risk factors or conditions such as type 2 diabetes or hypertension.

This product information is intended solely for pharmaceutical trade professionals, PCD pharma franchise partners, distributors, and institutional buyers. Atorable 10 Tablet is not promoted for direct consumer sale. All information is provided in accordance with applicable Indian pharmaceutical regulations.

Store in a cool, dry place below 25°C. Protect from direct sunlight and moisture. Keep the medicine out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation